Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 441 results for "ranbaxy lab"

Sun Pharma Ranbaxy Lab advance after closure of merger deal

Sun Pharmaceutical Industries and Ranbaxy Laboratories rose 1.25% to 1.46% at 15:15 IST on BSE after Sun Pharma announced closure of merger deal with Ranbaxy. The announcement was made during market hours today, 25 March 2015. Sun ... Capital Market, 3 weeks ago
Sun Pharma Ranbaxy Lab edge higher Capital Market, 3 weeks ago
Sun Pharma Ranbaxy Lab drop amid volatility Capital Market, 3 weeks ago

15 images for ranbaxy lab

Money Control, 2 weeks ago
NDTV Profit, 3 weeks ago
India Infoline, 1 month ago
Business Today India, 2 months ago
Money Today, 4 months ago
Financial Express, 4 months ago
Jagran Post, 4 months ago
Yahoo! News Australia, 5 months ago
Jagran Post, 4 months ago
Jagran Post, 4 months ago
Business Standard

Sun Pharma, SPARC hit new high on USFDA nod for ELEPSIA XR

SPARC surged 8% to Rs 445, Sun Pharma and Ranbaxy Lab rallied 6% each at Rs 997 and Rs 777 on BSE respectively. SI Reporter | Mumbai March 4, 2015 Last Updated at 10:59 IST Shares of Sun Pharmaceutical Industries and Sun Pharma Advanced Research Company ...
 Business Standard1 month ago Stocks in news: Infosys, Sun Pharma, JSPL, Glenmark, PNB  Money Control3 weeks ago Stocks in news: Sun Pharma, Deccan Gold, Century Tex, SAIL  Money Control3 weeks ago Pharma shares in demand; CNX Pharma index hits record high  Business Standard2 months ago
[x]  

Ranbaxy Lab slips as net loss widens in Q3

after the company reported consolidated net loss of Rs 1029.72 crore in Q3 December 2014, higher than net loss of Rs 158.94 crore in Q3 December 2013. The Q3 result was announced during market hours today, 28 January 2015. Meanwhile, the S BSE Sensex was down ...
 Business Standard2 months ago Sensex down over 100 pts; Bharti tanks 5%, Ranbaxy in focus  Money Control2 months ago Sensex under pressure; Bharti tanks 5%, Ranbaxy in focus  Money Control2 months ago
India Infoline

Ranbaxy Lab global HR head Udbhav Ganjoo quits

Report said that Udbhav Ganjoo may join multinational pharmaceutical firm Mylan.
 India Infoline1 month ago
Business Today India

Ranbaxy Laboratories : Sun to focus on R& D after Ranbaxy buyout

SUN Pharmaceutical announced the completion of its merger with Ranbaxy Labs on Wednesday and said it has formalised an operational blueprint for realising $ 250- million synergy target for three years. Sun Pharma said that the combined entity ...
 4 Traders3 weeks ago Sun Pharma to focus on R&D after Ranbaxy buyout  Business Today India3 weeks ago Sun completes Ranbaxy merger, to invest over $300 mn in R&D  Smart Investor3 weeks ago Ranbaxy in kitty, Sun Pharma to focus on R&D, global reach  Business Standard3 weeks ago
[x]  
Moneycontrol.com

Sensex maintains uptrend; Sun Pharma, Ranbaxy Labs gain 2%

Sun Pharma has been ready with the leadership team for Ranbaxy merger with self. The team included Aalok Shanghvi, who will lead business of both companies. He will also head emerging market business while Abhay Gandhi will be head domestic business and Kal ...
 Money Control1 month ago Ranbaxy merger: Sun Pharma readies new leadership team  Moneycontrol.com1 month ago
Money Control

Nifty above 8500; Ranbaxy Labs up 4%, auto stocks in focus

The market gained some strength amid consolidation in afternoon trade. The Sensex climbed 88.75 points to 28046.24 and the Nifty reclaimed 8500, up 21.90 points at 8512.90.
 Money Control2 weeks ago Nifty firm amid consolidation; Lupin, BPCL top gainers  Moneycontrol.com3 weeks ago Nifty reclaims 8600; Shasun Pharma surges, Aarti Drugs down  Moneycontrol.com3 weeks ago Sensex, Nifty rangebound; Tata Motors, MM, ONGC gainers  Moneycontrol.com3 weeks ago

Buy Ranbaxy Labs with a target of Rs 814: Sandeep Wagle.

In a chat with ET Now, Sandeep Wagle, Founder & CEO, Power My Wealth, shares his view on Ranbaxy. ET Now: What is your view on Ranbaxy? Sandeep Wagle: Ranbaxy Labs Ltd is a 'BUY' call with a target of Rs 814 and a stop loss of
 Economic Times1 month ago Buy Ranbaxy Labs; target of Rs 800: Motilal Oswal  Money Control2 months ago

Buy Ranbaxy Labs 780 Call: VK Sharma

VK Sharma of HDFC Securities recommends buying Ranbaxy Labs 780 Call.
 Money Control1 month ago Buy Lupin 1600 Call, Ranbaxy 740 Call: VK Sharma  Money Control2 months ago Buy Lupin 1500 call, Ranbaxy 700 Call: VK Sharma  Money Control2 months ago

Buy Ranbaxy with a target of Rs 850: Prakash Gaba

In a chat with ET Now, Prakash Gaba, CFT, prakashgaba.com, shares his view on Ranbaxy. ET Now: What is your view on Ranbaxy? Prakash Gaba: Ranbaxy Labs Ltd is a 'BUY' call with a target of Rs 850 and a stop loss of
 Economic Times1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less